SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-398545
Filing Date
2014-11-05
Accepted
2014-11-05 16:18:01
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d805094d10q.htm 10-Q 628016
2 EX-10.1 d805094dex101.htm EX-10.1 656337
3 EX-10.2 d805094dex102.htm EX-10.2 295833
4 EX-31.1 d805094dex311.htm EX-31.1 6521
5 EX-31.2 d805094dex312.htm EX-31.2 6125
6 EX-32.1 d805094dex321.htm EX-32.1 4100
  Complete submission text file 0001193125-14-398545.txt   5390567

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT alxa-20140930.xml EX-101.INS 581902
8 XBRL TAXONOMY EXTENSION SCHEMA alxa-20140930.xsd EX-101.SCH 41731
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20140930_cal.xml EX-101.CAL 59465
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20140930_def.xml EX-101.DEF 140382
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20140930_lab.xml EX-101.LAB 345391
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20140930_pre.xml EX-101.PRE 253551
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 141197180
SIC: 2834 Pharmaceutical Preparations